Assay DAI

$544,980U54FY2010MHNIH

Johns Hopkins University, Baltimore MD

Investigators

Linked publications & trials

Paper 28395140 Paper 28216001 Paper 27771940 Paper 26842342 Paper 26725739 Paper 26067272 Paper 26046436 Paper 25816897 Paper 25752739 Paper 25733897 Paper 25700001 Paper 25422141 Paper 25209672 Paper 25017033 Paper 24972239 Paper 24816792 Paper 24472174 Paper 24319319 Paper 24316074 Paper 24277843 Paper 24241348 Paper 24092046 Paper 24041654 Paper 23941274 Paper 23936032 Paper 23933114 Paper 23797855 Paper 23792947 Paper 23685953 Paper 23650395 Paper 23650380 Paper 23459091 Paper 23381110 Paper 23251633 Paper 22999378 Paper 22988107 Paper 22910039 Paper 22793372 Paper 22768937 Paper 22745159 Paper 22465069 Paper 22169478 Paper 22149888 Paper 22125664 Paper 22066912 Paper 21795696 Paper 21673715 Paper 21615117 Paper 21596989 Paper 21541288 Paper 21221420 Paper 21203351 Paper 21158688 Paper 21142151 Paper 21113317 Paper 20836709 Paper 20584905 Paper 20154678 Paper 20037152 Paper 19691494 Paper 19640222

Abstract

Assay Development, Adaptation and Implementation (DAI)Core Core Functions 1. Evaluate the suitability of JHICC capability in performing assays assigned by NIH and MLPCN 2. Manage the assay transfer 3. Determine milestones, schedule and deliverables to formulate compound probe development plan (CPDP) 4. Adapt and optimize assays transferred from assay providers 5. Determine and develop secondary assays 6. Prepare and finalize assessment of HTS-readiness 7. Maintain a steady supply of HTS-feasible or HTS-ready assays in pipeline.

View original record on NIH RePORTER →